The leucine-rich repeat (LRR) domain of NLRP3 is required for NLRP3 inflammasome activation in macrophages

• DOI: 10.1016/j.jbc.2022.102717
• Publication Date: 2022-11-17T16:05:14Z
• Authors: Yanhui Duan; Jihong Wang; Juan Cai; Nathan Kelley; Yuan He
• Keywords: 0301 basic medicine; 0303 health sciences; Inflammasomes; Macrophages; Interleukin-1beta; Immunity, Innate; Mice; 03 medical and health sciences; Leucine; NLR Family, Pyrin Domain-Containing 3 Protein; Animals; Research Article

AbstractThe NLRP3 inflammasome is a critical component of innate immunity that defends the host from microbial infections. However, its aberrant activation contributes to the pathogenesis of several inflammatory diseases. Activation of the NLRP3 inflammasome induces the secretion of proinflammatory cytokines IL-1β and IL-18, and pyroptotic cell death. NLRP3 contains a leucine-rich repeat (LRR) domain at its C-terminus. Although posttranslational modifications in this LRR domain have been shown to regulate NLRP3 inflammasome activation, the role of the entire LRR domain in NLRP3 inflammasome activation remains controversial. Here, we generated mouse macrophages that express an endogenous NLRP3 mutant lacking the LRR domain. Deletion of the LRR domain destabilized endogenous NLRP3 protein and abolished NLRP3 inflammasome activation in macrophages. Furthermore, using NLRP3-deficient macrophages that are reconstituted with NLRP3 mutants lacking the LRR domain, we found that deletion of the LRR domain inhibited NLRP3 inflammasome activation. Mechanistically, deletion of the LRR domain abolished NLRP3 self-association, oligomerization, and interaction with the essential regulator NEK7. Our results demonstrate a critical role for the LRR domain in NLRP3 inflammasome activation.